- Home
- SION vs AMLX Comparison
SION vs AMLX Comparison
Compare SION & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- AMLX
- Stock Information
- Founded
- SION 2019
- AMLX 2014
- Country
- SION United States
- AMLX United States
- Employees
- SION N/A
- AMLX N/A
- Industry
- SION
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- SION
- AMLX Health Care
- Exchange
- SION NYSE
- AMLX Nasdaq
- Market Cap
- SION 564.4M
- AMLX 459.1M
- IPO Year
- SION 2025
- AMLX 2022
- Fundamental
- Price
- SION $13.69
- AMLX $5.15
- Analyst Decision
- SION Strong Buy
- AMLX Buy
- Analyst Count
- SION 1
- AMLX 5
- Target Price
- SION $32.00
- AMLX $9.80
- AVG Volume (30 Days)
- SION 143.7K
- AMLX 1.1M
- Earning Date
- SION 05-12-2025
- AMLX 05-08-2025
- Dividend Yield
- SION N/A
- AMLX N/A
- EPS Growth
- SION N/A
- AMLX N/A
- EPS
- SION N/A
- AMLX N/A
- Revenue
- SION N/A
- AMLX N/A
- Revenue This Year
- SION N/A
- AMLX N/A
- Revenue Next Year
- SION N/A
- AMLX N/A
- P/E Ratio
- SION N/A
- AMLX N/A
- Revenue Growth
- SION N/A
- AMLX N/A
- 52 Week Low
- SION $7.26
- AMLX $1.58
- 52 Week High
- SION $25.19
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- SION N/A
- AMLX 56.51
- Support Level
- SION N/A
- AMLX $4.64
- Resistance Level
- SION N/A
- AMLX $5.40
- Average True Range (ATR)
- SION 0.00
- AMLX 0.39
- MACD
- SION 0.00
- AMLX -0.04
- Stochastic Oscillator
- SION 0.00
- AMLX 70.37
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.